Page 1 of 5, 222 articles total

New Treatment Approved for Rare Disease PKU May 25, 2018

Doptelet Approved for Liver Disease Patients Slated for a Medical Procedure May 21, 2018

Aimovig Approved to Prevent Migraines May 18, 2018

Non-Opioid Treatment Approved for Opioid Withdrawal May 17, 2018

'BioSimilar' Drug Approved to Treat Certain Types of Anemia May 15, 2018

Use of MS Drug Expanded to Include Children May 14, 2018

New Device Cleared for Gastrointestinal Bleeding May 07, 2018

Drug Duo Approved for Aggressive Thyroid Cancer May 04, 2018

First Auto-Darken Contact Lenses Approved April 10, 2018

Blincyto Approval Expanded for Specific Leukemia March 29, 2018

Adcetris Approval Expanded to Include Later-Stage Hodgkin Lymphoma March 20, 2018

First Screening Tests Approved for Tickborne Parasite March 07, 2018

New Medication Approved for Drug-Resistant HIV March 06, 2018

Mechanical Heart Valve Approved for Newborns March 06, 2018

First Blood Test to Evaluate Potential Concussions Approved February 14, 2018

New Treatment Approved for Prostate Cancer That Resists Hormone Therapy February 14, 2018

Lutathera Approved for Some Gastro and Pancreatic Cancers January 26, 2018

First Treatment Approved for Breast Cancer Caused by Specific Gene Mutation January 12, 2018

Gene Therapy Approved for Rare Inherited Vision-Loss Disorders December 19, 2017

First Drug Approved for Rare Condition That Inflames Blood Vessels December 12, 2017

New Diabetes Drug Gets FDA OK Under 'Abbreviated' Pathway December 11, 2017

Ozempic Approved for Type 2 Diabetes December 06, 2017

Once-Monthly Injection Approved for Opioid Addiction December 01, 2017

FDA Approves 'Biosimilar' Drug Ogivri for Breast, Stomach Cancers December 01, 2017

New Hemophilia Treatment Stems Bleeding Episodes November 16, 2017

Mepsevii Approved for Rare Enzyme Disorder November 15, 2017

'Digital Pill' Tells Doctor When Patient Takes It November 14, 2017

Zelboraf Approved for Rare Blood Cancer November 06, 2017

Calquence Approved for Mantle Cell Lymphoma October 31, 2017

Gene Therapy Approved for B-Cell Lymphoma October 19, 2017

The first such treatment for non-Hodgkin form of this cancer

Remede System Approved for Sleep Apnea October 09, 2017

Implantable device stimulates breathing during sleep

First Test to Detect Zika in Blood Donations Approved October 06, 2017

Not designed to diagnose the infection, however

Verzenio Approved for Advanced Breast Cancer September 29, 2017

The most common cancer in the United States

Glucose Monitoring System Eliminates Need for Finger Pricks September 28, 2017

Instead, sensor is implanted below skin in diabetes patients

Mvasi Is First Biosimilar Drug Approved for Cancer September 14, 2017

Similar to Avastin

Aliqopa Approved for Follicular Lymphoma September 14, 2017

A cancer of the lymph system

App to Help Treat Substance Abuse Approved September 14, 2017

But app is not recommended for opioid dependence

Pediatric Treatment Approved for 'Kissing Bug' Disease August 30, 2017

Benznidazole sanctioned for Chagas infection

Antibiotic Vabomere Approved August 30, 2017

For complicated urinary tract infections

First Gene Therapy Approved in U.S. August 30, 2017

For certain people with blood/bone marrow cancer

New Treatment Approved for Deadly Blood Cancer August 17, 2017

Acute lymphoblastic leukemia

Mavyret Approved for Hepatitis C August 04, 2017

A chronic viral infection of the liver

New Treatment Approved for Acute Myeloid Leukemia August 03, 2017

Vyxeos combines two previously approved drugs

Imbruvica Approval Expanded to Include Graft Versus Host Disease August 02, 2017

A deadly condition that affects some stem cell patients

Idhifa Approved for Some With Acute Myeloid Leukemia August 01, 2017

For adults with specific genetic mutation

MRI Approved for Young Infants in Intensive Care July 20, 2017

Device designed for neonatal brain and head imaging

Nerlynx Approved to Help Prevent Breast Cancer's Return July 18, 2017

Drug is designed to block cancer-fueling enzymes

New Drug Approved for All Cancers With Genetic Marker May 24, 2017

First medication sanctioned for any cancer, regardless of origin

Actemra Approved for Certain Blood Vessel Inflammation May 22, 2017

Drug will treat adults with a condition called vasculitis

Kalydeco Approval Widened for More Types of Cystic Fibrosis May 18, 2017

Laboratory evidence used to expand approval

NAVIGATION WE ARE HERE TO HELP YOU! STAY CONNECTED Like Tweet Share Pin it Follow Instagram